A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/554 (2006.01) A61K 31/4045 (2006.01) A61K 31/428 (2006.01) A61K 31/473 (2006.01) A61K 31/48 (2006.01) A61K 31/4985 (2006.01) A61K 31/519 (2006.01) A61K 31/5513 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2622696
Methods and compositions for preventing or reducing weight gain and associated metabolic syndrome in patients receiving atypical antipsychotic drugs for treatment of mental illnesses are described. The invention comprises administering to a patient in need of treatment an effective amount of a dopamine agonist in conjunction with an effective amount of an atypical antipsychotic drug. In one embodiment of the invention, the dopamine agonist is pramipexole. The dopamine agonist may be administered in a low dose, such as less than 1 mg per day of pramipexole. Examples of atypical antipsychotic drugs which may be administered in conjunction with the dopamine agonist include clozapine, olanzapine, quetiapine and risperadone.
Kjernisted Kevin
Mcintosh Diane
Kjernisted Kevin
Mcintosh Diane
Oyen Wiggs Green & Mutala Llp
LandOfFree
Methods and compositions for retarding weight gain... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for retarding weight gain..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for retarding weight gain... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1545096